Journal article icon

Journal article

Who will benefit more from low-dose alteplase in acute ischemic stroke?

Abstract:

Objectives: Controversy persists over the benefits of low-dose versus standard-dose intravenous alteplase for the treatment of acute ischemic stroke. We sought to determine individual patient factors that contribute to the risk–benefit balance of low-dose alteplase treatment.

Methods: Observational study using data from the Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED), an international, randomized, open-label, blinded-e...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1177/1747493019858775

Authors


More by this author
Institution:
University of Oxford
Department:
Women’s & Reproductive Health
Department:
Oxford, MSD, Womens & Reproductive Health
Role:
Author
Publisher:
SAGE Publications
Journal:
International Journal of Stroke More from this journal
Volume:
15
Issue:
1
Pages:
39-45
Publication date:
2019-06-21
Acceptance date:
2018-12-21
DOI:
EISSN:
1747-4949
ISSN:
1747-4930
Language:
English
Keywords:
Pubs id:
pubs:956010
UUID:
uuid:a896638d-d1a0-4d6f-9103-c4819c44ee18
Local pid:
pubs:956010
Source identifiers:
956010
Deposit date:
2019-01-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP